Late recurrence of an embryonal carcinoma of the testis. Case report

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

Published Jun 30, 2015
DOI: https://doi.org/10.22551/2015.06.0202.10033
Luminita Gurguta Mihai V Marinca

Abstract

We present the case of a 32-year old male, diagnosed in 2003 (at the age of 22) with stage IIB testicular cancer. After orchiectomy he had received 4 cycles of chemotherapy (BEP protocol). In 2013 the disease relapsed (S2-level tumor markers, multiple lung metastases, compressive and invasive abdomino-pelvic adenopathy). Performance status (PS) at presentation was poor (ECOG PS 2), he reported diffuse abdominal pain (VAS 5) and deep vein thrombosis in the right leg. Salvage chemotherapy (TIP protocol) was administered for 6 cycles, with grade 2-3 hematologic toxicity. Post-treatment evaluation revealed a good partial response: single pulmonary nodule (no FDG uptake), and 4.4-cm intraabdominal mass (SUV 6.0). Non-nerve-sparing salvage right retroperitoneal lymph node dissection was decided, and one microscopic focus of embryonal carcinoma was the only postoperative pathology finding. The patient is currently disease-free.

##plugins.themes.bootstrap3.article.details##

Keywords

NSGCT, late relapse, salvage chemotherapy, response evaluation

References
1. Casciato DA, Territo MC. Manual of Clinical Oncology, 7th Edition. Philadelphia: Lippincott Williams & Wilkins, 2012.
2. Hussain SA, Ma YT, Cullen MH. Management of metastatic germ cell tumors. Expert Rev Anticancer Ther 2008; 8(5):771–784.
3. Albers P. Diagnosis, staging, and risk factors: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology 2011; 78:S427-434.
4. Nakamura T, Miki T. Recent strategy for the management of advanced testicular cancer. Int J Urol 2010; 17(2):148-157.
5. Motzer RJ, Agarwal N, Beard C, et al. Testicular cancer. J Natl Compr Canc Netw 2009; 7(6):672-693.
6. Kollmannsberger C, Honecker F, Bokemeyer C. Pharmacotherapy of relapsed metastatic testicular cancer. Expert Opin Pharmacother 2008; 9(13):2259-2272.
7. Khurana K, Gilligan TD, Stephenson AJ. Management of poor-prognosis testicular germ cell tumors. Indian J Urol 2010; 26(1):108-114.
8. Herdrich K, Weinberger H. Selected schedules in the therapy of malignant tumors, 17th Edition. Deerfield: Baxter International Inc, 2013.
9. Beyer, S. Stenning, A. Gerl, et al. High-dose versus conventional-dose chemotherapy as first salvage therapy in patients with non-seminomatous germ-cell tumours: a matched pair analysis. Ann Oncol 2002; 13:599-605.
10. NCCN Clinical Practice Guidelines in Oncology. Testicular cancer, v2.2015 [http://www.nccn.org/professionals/physician_gls/pdf/testicular.pdf available at 05/13/2015].
11. Oldenburg, Fosså SD, J. Nuver J, et al. Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines. Ann Oncol 2013; 24(suppl 6):vi125-vi132.
12. Nastały P, Ruf C, Becker P, et al. Circulating tumor cells in patients with testicular germ cell tumors. Clin Cancer Res 2014; 20(14):3830-3841.
13. Fizazi K, Oldenburg J, Dunant A, et al. Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results from the sCR2 international study. Ann Oncol 2008; 19(2):259-264.
14. Kondagunta GV, Bacik J, Donadio A, et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 2005; 23(27):6449-6555.
15. International Prognostic Factors Study Group, Lorch A, Beyer J, et al. Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J Clin Oncol 2010; 28(33):4906-4911.
16. Oldenburg J, Wahlqvist R, Fosså SD. Late relapse of germ cell tumors. World J Urol 2009; 27(4):493-500.
How to Cite
Gurguta, L., & Marinca, M. V. (2015). Late recurrence of an embryonal carcinoma of the testis. Case report. Archive of Clinical Cases, 2(2), Arch Clin Cases 2015; 2(2):53-57. https://doi.org/10.22551/2015.06.0202.10033
Issue
Vol. 2 No. 2 (2015)
Section
Case Reports

Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.

Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.

Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.

How to Cite

Gurguta, L., & Marinca, M. V. (2015). Late recurrence of an embryonal carcinoma of the testis. Case report. Archive of Clinical Cases, 2(2), Arch Clin Cases 2015; 2(2):53-57. https://doi.org/10.22551/2015.06.0202.10033